|
| 38073017 | Different Immunologic Profiles Are Associated With Distinct Clinical Phenotypes in Longitudinally Observed Patients With Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2024 |
| 37964675 | The Effects of Systemic Lupus-Related Cognitive Impairments on Activities of Daily Living and Life Role Participation: A Qualitative Framework Study. | ACR Open Rheumatol | 2024 |
| 34344704 | Response to: Correspondence on "New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE" by Pons-Estel <i>et al</i>. | Ann Rheum Dis | 2023 |
| 37967910 | More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus. | J Rheumatol | 2023 |
| 37993371 | Systemic lupus erythematosus and damage: What has changed over the past 20 years? | Best Pract Res Clin Rheumatol | 2023 |
| 35724303 | Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus. | Arthritis Care Res (Hoboken) | 2023 |
| 35686931 | Trajectories of depressive symptoms in systemic lupus erythematosus over time. | Rheumatology (Oxford) | 2023 |
| 37125665 | Correspondence on "relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus" by Chi Chiu Mok et al. | Lupus | 2023 |
| 37349123 | Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force. | RMD Open | 2023 |
| 37036020 | In-person versus virtual administration of the American College of Rheumatology gold standard cognitive battery in systemic lupus erythematosus: Are they interchangeable? | Lupus | 2023 |
| 37429671 | Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE. | Lupus Sci Med | 2023 |
| 36651668 | Genetics of osteonecrosis in children and adults with systemic lupus erythematosus. | Rheumatology (Oxford) | 2023 |
| 36916720 | Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus. | Rheumatology (Oxford) | 2023 |
| 36912276 | Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group. | Lupus | 2023 |
| 36801812 | What is a response in randomised controlled trials in giant cell arteritis? | Ann Rheum Dis | 2023 |
| 36765391 | Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA<sup>+</sup> individuals without a systemic autoimmune rheumatic disease diagnosis. | Arthritis Res Ther | 2023 |
| 36503376 | Improving measures of disease activity in systemic lupus erythematosus. | Expert Rev Clin Immunol | 2023 |
| 36705542 | Intraindividual Change in Cognitive Function Among Adults With Systemic Lupus Erythematosus: A Markov Analysis Over 7â¿¿Years. | ACR Open Rheumatol | 2023 |
| 36135792 | Association of mycophenolate and azathioprine use with cognitive function in systemic lupus. | Rheumatology (Oxford) | 2023 |
| 36394258 | Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairment. | Rheumatology (Oxford) | 2023 |
| 36319012 | Evaluating the Threshold Score for Classification of Systemic Lupus Erythematosus Using the EULAR/ACR Criteria. | J Rheumatol | 2023 |
| 34962100 | Evaluating the Construct of Damage in Systemic Lupus Erythematosus. | Arthritis Care Res (Hoboken) | 2023 |
| 34486829 | Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing. | Arthritis Care Res (Hoboken) | 2023 |
| 33345456 | Systemic Lupus Erythematosus Symptom Clusters and Their Association With Patient-Reported Outcomes and Treatment: Analysis of Real-World Data. | Arthritis Care Res (Hoboken) | 2022 |
| 35844549 | Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear Antibodies. | Front Immunol | 2022 |
| 35711439 | Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis. | Front Immunol | 2022 |
| 35932197 | A Review of Lupus Nephritis. | J Appl Lab Med | 2022 |
| 36219896 | The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomes. | Semin Arthritis Rheum | 2022 |
| 36007978 | Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN). | Lupus Sci Med | 2022 |
| 35017186 | Herpes zoster in SLE: prevalence, incidence and risk factors. | Lupus Sci Med | 2022 |
| 34913146 | Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management. | Drugs Aging | 2022 |
| 34905485 | Real-world impact of flaring on patient-reported outcomes and healthcare resource utilisation in systemic lupus erythematosus. | Clin Exp Rheumatol | 2022 |
| 35105713 | COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls. | J Rheumatol | 2022 |
| 35019971 | What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature? | Rheumatology (Oxford) | 2022 |
| 34957878 | Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus. | Lupus | 2022 |
| 34498056 | Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study. | Rheumatology (Oxford) | 2022 |
| 34175923 | Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals. | Rheumatology (Oxford) | 2022 |
| 32433815 | Identifying a Response for the Systemic Lupus Erythematosus Disease Activity 2000 Glucocorticoid Index. | Arthritis Care Res (Hoboken) | 2021 |
| 33568386 | European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. | Ann Rheum Dis | 2021 |
| 33506863 | Comment on: Association between depression and anxiety with skin and musculoskeletal clinical phenotypes in systemic lupus erythematosus: reply. | Rheumatology (Oxford) | 2021 |
| 33775461 | Endorsement of the domains of knee and hip osteoarthritis (OA) flare: A report from the OMERACT 2020 inaugural virtual consensus vote from the flares in OA working group. | Semin Arthritis Rheum | 2021 |
| 34610995 | Insight into intraindividual variability across neuropsychological tests and its association with cognitive dysfunction in patients with lupus. | Lupus Sci Med | 2021 |
| 34607183 | Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus. | Semin Arthritis Rheum | 2021 |
| 34544617 | The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2. | Semin Arthritis Rheum | 2021 |
| 34797991 | Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous. | Lupus | 2021 |
| 34045359 | Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus. | Lupus Sci Med | 2021 |
| 34157577 | Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review. | Semin Arthritis Rheum | 2021 |
| 34215379 | Systemic Lupus Erythematosus: The Next Generation of Ideas and Scientists. | Rheum Dis Clin North Am | 2021 |
| 34215371 | Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials. | Rheum Dis Clin North Am | 2021 |
| 34264148 | Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: A systematic review. | Lupus | 2021 |